“…Synthetic polypeptides have displayed great potentials in the biomedical field and are regarded as promising candidates for the design of drug carriers due to their desired biocompatibility and biodegradability. − As protein mimics, polypeptides can adopt ordered secondary structures (e.g., α-helix and β-sheet) through hydrogen bonding interactions between backbone peptide bonds, − which endow them with conformation-specific assembly behaviors and biomedical functions. − For instance, cationic polypeptides with α-helical structures exhibit much higher membrane-penetrating activity than their random-coiled analogues, which are internalized through the “pore-formation” mechanism. − Through proper side-chain design, α-helical, cationic polypeptides have been widely studied to promote the intracellular delivery of molecular cargos or to facilitate the design of antimicrobial or antitumor polymers. − Additionally, amphiphilic polypeptides with α-helical hydrophobic segments tend to self-assemble into vesicles due to the parallel arrangement of rigid helices, while their β-sheet and random-coiled analogues are more likely to form micelles. ,, Due to the distinct differences of materials properties between helical and random-coiled conformation, conformation-switchable polypeptides are designed and synthesized to manipulate their biomedical functions in situ . The transition of secondary structures is achieved through the fine-tuning of side-chain interactions including electrostatic interactions, − polarity, − hydrogen bonds, coordination interaction, and base-pairing interactions, which activates or deactivates the helix-associated functions under desired conditions.…”